Letter to the Editor: Is Aspirin a Drug or Just a Marker for Biliary Cancer?
Jun‐Wei Zhang, Xu Yang, Hui‐Ru Ding, Lei Zhang, Yi‐Yao Xu, Xin‐Ting Sang, Hai‐Tao Zhao, Wei‐Guang Zhang, Xin Lu – 8 July 2021
Jun‐Wei Zhang, Xu Yang, Hui‐Ru Ding, Lei Zhang, Yi‐Yao Xu, Xin‐Ting Sang, Hai‐Tao Zhao, Wei‐Guang Zhang, Xin Lu – 8 July 2021
8 July 2021
8 July 2021
8 July 2021
James M. Paik, Seema Mir, Saleh A. Alqahtani, Youssef Younossi, Janus P. Ong, Zobair M. Younossi – 7 July 2021 – Nonalcoholic fatty liver disease (NAFLD) is a common but complex chronic liver disease, driven by environmental and genetic factors. We assessed metabolic and dietary risk factor associations with NAFLD liver mortality using the Global Burden of Disease (GBD) 2017 data. NAFLD liver deaths were calculated (per 100,000) as age‐standardized rates (ASRs) from 195 countries and territories (21 GBD regions; 7 GBD superregions).
Catherine C. Cohen, Eduardo Castillo‐Leon, Alton B. Farris, Shelley A. Caltharp, Rebecca L. Cleeton, Elizabeth M. Sinclair, Diane E. Shevell, Morten A. Karsdal, Mette Juul Fisker Nielsen, Diana J. Leeming, Miriam B. Vos – 7 July 2021 – Nonalcoholic fatty liver disease (NAFLD) is a common chronic liver disease in children and may lead to cirrhosis requiring liver transplant. Thus, prompt diagnosis of advanced fibrosis is essential.
Mei‐Hsuan Lee, Yi‐Hsiang Huang, Jill Koshiol – 7 July 2021
Yufeng Hu, Wenzhi He, Yongping Huang, Hui Xiang, Juan Guo, Yan Che, Xu Cheng, Fengjiao Hu, Manli Hu, Tengfei Ma, Jie Yu, Han Tian, Song Tian, Yan‐Xiao Ji, Peng Zhang, Zhi‐Gang She, Xiao‐Jing Zhang, Zan Huang, Juan Yang, Hongliang Li – 6 July 2021